Navigation Links
St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory
Date:10/18/2007

ltiply to form retinoblastoma also challenges the established scientific belief that cancer cells are most aggressive when they are undifferentiated, Dyer said. For example, the leukemic cells of chronic myelogeneous leukemia (CML) are much less aggressive when they are differentiated; and it is generally not aggressive until the tumor cells sustain mutations that block differentiation.

On the contrary, we showed that when certain genes are inactivated in the retina, horizontal neurons that are already differentiated and fully integrated into the brain can start multiplying rapidly and produce a very aggressive cancer, Dyer said. This opens an exciting new chapter in the study of neurons and brain tumors.

An important implication of this finding is that if researchers were able to alter the activity of certain genes in fully developed neurons, they might be able to trigger them to multiply temporarily and replace the neighboring neurons that were lost as a result of neurodegenerative diseases such as Alzheimers, Dyer said. Having nerves duplicate themselves might be more efficient than trying to stimulate nerve replacement by inserting stem cells into the brain, since the existing nerves would already be in the right place to restore missing brain cells, he said. However, there is still a lot of research required to determine if it is possible to control gene activity to make this approach practical.

Dyers group made their discovery by developing different populations of mice whose retinas lacked one or more members of the Rb family of genes that include Rb, p107 and p130. This family of related genes is critical to the ability of an immature cell to stop dividing and begin to differentiate so it acquires certain specific characteristics required to do its job in the body.

The St. Jude researchers showed that when the mouse retina had reduced Rb family function, fully differentiated horizontal neurons could multiply while ret
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-495-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
2. New lab technique identifies high levels of pathogens in therapy pool
3. Study identifies gene in mice that may control risk-taking behavior in humans
4. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
5. U. of Colorado researcher identifies tracks of swimming dinosaur in Wyoming
6. Model identifies genes that induce normal skin cells to become abnormal
7. New study identifies key gene in development of connections between brain and spinal cord
8. New HIV study identifies high-risk subgroups of adolescents
9. Research identifies protein in mice that regulates bone formation
10. Study identifies new role for breast cancer susceptibility gene
11. New strategy rapidly identifies cancer targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... change in warmer water, according to an intriguing new study ... , Experiments with two species of young damselfish on Australia,s ... some reef fish are either consistently timid, or consistently bold, ... water temperatures rise. , A slight lift of just one ...
(Date:12/3/2009)... A team of scientists from the U.S. Department ... the Indian Institute of Science has made a major ... in DNA that is necessary to carry out important ... 2009 edition of Nature Structural & Molecular Biology ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3HealthFitness Makes Compelling Case for Employee Health Management 51822 1HealthFitness Makes Compelling Case for Employee Health Management 51822 2Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 1Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 1St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 3St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 4
... Called granulosa cells, they surround eggs and deliver nutrients ... be successfully fertilized. , How do these handmaidens grow? ... have discovered that two proteins ?TAF4b and c-Jun ?team ... the nuclei of granulosa cells. This subset of genes, ...
... bone-marrow derived stem cells can regenerate damaged renal cells ... potential new strategy for managing this inherited kidney disease ... may be useful in repairing basement membrane matrix defects ... at Beth Israel Deaconess Medical Center (BIDMC), the findings ...
... sea experiments shows there's a constant shuffling of genetic ... they use seems to be a flood of viruses, ... Professor Sally W. Chisholm, is uncovering a challenging new ... manage to exploit changing conditions such as altered light, ...
Other Biology News:A surprising pair of proteins help make healthy eggs 2New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease 2MIT: Oceans are a major gene swap-meet for plankton 2MIT: Oceans are a major gene swap-meet for plankton 3MIT: Oceans are a major gene swap-meet for plankton 4
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... recall of five lots and voluntary market withdrawal of ... ® . Shire is taking this action because some ... may not meet their release liner removal specification, and ...
(Date:12/3/2009)... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief ... http://www.beikebiotech.com ), spoke at a conference on ... 22, 2009. Beike is China,s leading,stem cell research ... The conference, organized by the Indian Podiatry ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Carbondioxide Incubators - A Global Market ... ,, Incubators are the most critical equipment ... other applications for providing a controlled environment ...
(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... Epeius Biotechnologies,Corporation today announced that Rexin-G has ... and Drug Administration (FDA) for the,treatment of all ... third,clinical indication for which Rexin-G has been formally ... latest approval for Rexin-G validates the,company,s remarkable strategy ...
... 8, 2008Biotech and pharmaceutical firms are developing a ... complicated drug discovery process, reports Genetic Engineering ... successful approaches rely on a combination of high-throughput ... according to an article in the July issue ...
... in nanoscale lithographic technology, used in the manufacture of ... patterns of lines over larger areas than have been ... could pave the way for next-generation computer memory and ... other devices. , The team has created lines about ...
Other Biology Technology:FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3MIT reports finer lines for microchips 2
... Mouse monoclonal [YPF19] to Yersinia ... to detect Yersinia pestis . ... from Yersinia pestis vaccine ... This antibody recognises Y.pestis F1 capsular ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Biology Products: